H
Horizon Therapeutics PLC
F:HPR
Horizon Therapeutics PLC
F:HPR
Price:
110.2
EUR
Market Cap:
€25.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Horizon Therapeutics PLC
F:HPR
|
IE |
|
SKS Technologies Group Ltd
ASX:SKS
|
AU |
|
C
|
Canadian Uranium Corp
OTC:CANUF
|
CA |
|
W
|
Welcron Co Ltd
KOSDAQ:065950
|
KR |
|
Velan Inc
TSX:VLN
|
CA |
|
TransAlta Renewables Inc
TSX:RNW
|
CA |
|
S
|
Sansei Landic Co Ltd
TSE:3277
|
JP |
|
H
|
Hyundai Green Food Co Ltd
KRX:005440
|
KR |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SSE:600521
|
CN |
|
Comforia Residential Reit Inc
TSE:3282
|
JP |
|
T
|
TNS Holdings JSC
VN:TN1
|
VN |
|
Media Chinese International Ltd
HKEX:685
|
HK |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of HPR.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HPR
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
HPR Competitors Multiples
Horizon Therapeutics PLC Competitors
Horizon Therapeutics PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IE |
H
|
Horizon Therapeutics PLC
F:HPR
|
25.2B EUR | 8.2 | 67.8 | 31.1 | 52.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.8B USD | 6.1 | 88.6 | 14.7 | 20.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.3B USD | 5.1 | 24.2 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.3B USD | 5.9 | 20.5 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.7B USD | 9.3 | 28.3 | 21.2 | 22.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.4B USD | 5.7 | 18 | 13.5 | 15.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD | 3 | 33.6 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR | 11.6 | 37.3 | 40.7 | 41.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
